Key Details
Price
$116.30Annual Revenue
$3.63 BAnnual EPS
$2.22PE Ratio
62.19Annual ROE
10.70%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Nov 02, 2023Recent annual earnings:
Mar 01, 2023Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Horizon Therapeutics (HZNP) shares jumped more than 5.5% in early trading Monday after the FTC said it would suspend its challenge to Amgen's (AMGN) acquisition of the drug maker.
The Federal Trade Commission suspends its ongoing lawsuit to block Horizon's (HZNP) acquisition by Amgen until Sep 18, 2023. The company's stock rises 5.8% in response.
Horizon (HZNP) reports better-than-expected second-quarter results, beating both earnings and sales estimates, with the top-line key contributors being Krystexxa and Uplizna.
Horizon Therapeutics (HZNP) came out with quarterly earnings of $1.20 per share, beating the Zacks Consensus Estimate of $1.12 per share. This compares to earnings of $1.07 per share a year ago.
The headline numbers for Horizon Therapeutics (HZNP) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Horizon (HZNP) fails to meet the primary endpoint in the mid-stage study of evaluating daxdilimab in the treatment of systemic lupus erythematosus.
Horizon Therapeutics (HZNP) reported earnings 30 days ago. What's next for the stock?
Last December, Amgen and Horizon agreed to a $27.8 billion buyout agreement. This proposed deal is now in doubt following a report that the FTC plans on challenging the takeover in federal court.
Horizon Therapeutics (NASDAQ: HZNP ) stock is sinking 18% this morning. The Federal Trade Commission (FTC) is reportedly attempting to block the drug maker's proposed merger with Amgen (NASDAQ: AMGN ).
The Dow and S&P 500 moved lower Tuesday morning. Sea Limited shares fell as the company's video game segment failed to meet expectations.
FAQ
- What is the primary business of Horizon Therapeutics Public Limited?
- What is the ticker symbol for Horizon Therapeutics Public Limited?
- Does Horizon Therapeutics Public Limited pay dividends?
- What sector is Horizon Therapeutics Public Limited in?
- What industry is Horizon Therapeutics Public Limited in?
- What country is Horizon Therapeutics Public Limited based in?
- When did Horizon Therapeutics Public Limited go public?
- Is Horizon Therapeutics Public Limited in the S&P 500?
- Is Horizon Therapeutics Public Limited in the NASDAQ 100?
- Is Horizon Therapeutics Public Limited in the Dow Jones?
- When was Horizon Therapeutics Public Limited's last earnings report?
- When does Horizon Therapeutics Public Limited report earnings?
- Should I buy Horizon Therapeutics Public Limited stock now?